연구자료
Phase I clinical trial of safety of L-serine for ALS patients
논문 요약(발췌)
Abstract We performed a randomized, double-blind phase I clinical trial for six months on the effects of oral L-serine in patients with ALS. The protocol called for enrollment of patients with a diagnosis of probable or definite ALS, age 18–85 years, disease duration of less than three years and forced vital capacity (FVC) ≥ 60%. Patients were randomly assigned to four different oral twice-daily dose regimens (0.5, …
소비자 설명
Abstract We performed a randomized, double-blind phase I clinical trial for six months on the effects of oral L-serine i…
Source: https://www.tandfonline.com/doi/full/10.1080/21678421.2016.1221971